GLA Antikörper (AA 83-112)
Kurzübersicht für GLA Antikörper (AA 83-112) (ABIN7876930)
Target
Alle GLA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 83-112
-
Verwendungszweck
- Galactosidase alpha Antibody / Gla
-
Aufreinigung
- Purified
-
Immunogen
- A portion of amino acids 83-112 from the human protein was used as the immunogen for the Galactosidase alpha antibody.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- The stated application concentrations are suggested starting points. Titration of the Galactosidase alpha antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the Galactosidase alpha antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- GLA (Galactosidase, alpha (GLA))
-
Andere Bezeichnung
- Galactosidase alpha
-
Hintergrund
- GLA is a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties.
-
UniProt
- P06280
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-